I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Adherencia al tratamiento con adalimumab, golimumab y ustek..:
Calvo Arbeloa, María
;
Insausti Serrano, Ana María
;
Arrondo Velasco, Amaya
.
Farmacia Hospitalaria, 2020, 44(2), 62-67. ,
Link:
https://hdl.handle.net/2454/39390
RT Journal T1
Adherencia al tratamiento con adalimumab, golimumab y ustekinumab en pacientes con enfermedad inflamatoria intestinal ; Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
UL https://suche.suub.uni-bremen.de/peid=base-ftunivpnavarra:oai:academica-e.unavarra.es:2454_39390&Exemplar=1&LAN=DE A1 Calvo Arbeloa, María A1 Insausti Serrano, Ana María A1 Arrondo Velasco, Amaya A1 Sarobe Carricas, María Teresa PB Aula Médica Ediciones; Sociedad Española de Farmacia Hospitalaria (SEFH) K1 Adherencia terapéutica K1 Terapia biológica K1 Adalimumab K1 Golimumab K1 Ustekinumab K1 Enfermedad inflamatoria intestinal K1 Therapeutic adherence K1 Biological therapy K1 Inflammatory bowel disease JF Farmacia Hospitalaria, 2020, 44(2), 62-67 LK http://dx.doi.org/https://hdl.handle.net/2454/39390 DO https://hdl.handle.net/2454/39390 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)